Key result
Transapical aortic valve implantation in high-risk patients requiring redo surgery achieved a 96% procedural success rate and an 88% 30-day survival rate with no new-onset neurological events.
Why the study?
Does transapical aortic valve implantation provide safe and effective outcomes in high-risk patients with symptomatic aortic valve stenosis requiring redo cardiac surgery?
Population
25 high-risk patients with symptomatic aortic valve stenosis and previous cardiac surgical interventions…
Design
Case_series
Follow-up
1 year
Authors
Loading...
Should not yet change practice in high-risk redo cases; leaves open need for prospective confirmation.
Observational (n=25)
Does transapical aortic valve implantation provide safe and effective outcomes in high-risk patients with symptomatic aortic valve stenosis requiring redo cardiac surgery?
Transapical aortic valve implantation is a feasible and effective alternative to conventional surgery with minimal stroke risk for elderly, high-risk patients requiring redo cardiac procedures.
Walther et al. (2009) conducted an observational in Symptomatic aortic valve stenosis requiring redo surgery (n=25). Transapical aortic valve implantation (TA-AVI) was evaluated on 30-day survival. Transapical aortic valve implantation in high-risk patients requiring redo surgery achieved a 96% procedural success rate and an 88% 30-day survival rate with no new-onset neurological events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: